无张力阴道吊带术与聚丙烯酰胺水凝胶注射治疗原发性压力性尿失禁的随机临床试验
这项非劣效性随机对照试验纳入224例原发性压力性尿失禁女性,比较无张力阴道吊带术(TVT)与聚丙烯酰胺水凝胶注射的疗效。1年随访时,TVT组患者满意度评分≥80的比例为95.0%,水凝胶组为59.8%,水凝胶未达到预设的非劣效界值。TVT疗效更优但并发症更多,水凝胶可作为替代选择。
要点
- TVT组1年满意度(VAS≥80)达95.0%,水凝胶组仅59.8%,未达非劣效。
- 咳嗽压力试验阴性率TVT组95.0% vs 水凝胶组66.4%(差28.6%,95%CI 18.4-38.5)。
- 围手术期并发症及再次手术主要与TVT相关,水凝胶并发症较少。
核心结论
- TVT吊带术在满意度和治愈率上优于聚丙烯酰胺水凝胶,但并发症主要与TVT相关。
- 对期望首次治疗即完全治愈且愿接受并发症风险者,TVT应作为一线治疗。
- 水凝胶也可提供较高的满意度和治愈率,可作为原发性压力性尿失禁的替代治疗。
研究设计与样本
- 随机对照非劣效性临床试验,纳入224例原发性压力性尿失禁女性。
- TVT组111例,聚丙烯酰胺水凝胶组113例,随访1年。
- 非劣效界值设为20%,检验水准5%,把握度80%,预期脱落率10%。
主要发现
- 1年时VAS满意度评分≥80者TVT组95.0%,水凝胶组59.8%,水凝胶未达非劣效标准。
- 咳嗽压力试验阴性率TVT组95.0% vs 水凝胶组66.4%(差28.6%,95%CI 18.4-38.5)。
- 围手术期并发症TVT组19例 vs 水凝胶组3例(差16.0%,95%CI 7.8-24.9)。
- 因并发症再次手术共6例,均发生在TVT组(差5.9%,95%CI 1.2-12.4)。
关键数值与推荐
- 主要结局为患者满意度(VAS 0-100,≥80为满意)。
- 次要结局为减少尿漏的有效性和并发症,随访1年。
- 非劣效界值为20%,检验水准5%,把握度80%。
临床怎么用
- 对期望首次治疗完全治愈且能接受并发症风险的患者,优先推荐TVT。
- 水凝胶注射可作为不愿承担TVT并发症风险患者的替代方案。
- 术前咨询应告知TVT疗效更高但并发症及再手术风险也更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluated whether polyacrylamide hydrogel is noninferior to tension-free vaginal tape to treat women with primary stress urinary incontinence. MATERIALS AND METHODS: In this controlled noninferiority clinical trial patients with primary stress urinary incontinence were randomized to tension-free vaginal tape or polyacrylamide hydrogel treatment. The primary outcome was patient satisfaction and secondary outcomes were effectiveness in reducing urinary leakage and complications at 1-year followup. For statistical power significance was considered at 5%, power was set at 80% and the noninferiority limit was 20% with a 10% expected dropout rate. RESULTS: A total of 224 women with primary stress urinary incontinence entered the study between September 28, 2015 and March 1, 2017. Of the women 111 were randomized to tension-free vaginal tape and 113 were randomized to polyacrylamide hydrogel. At 1 year a satisfaction score of 80 or greater on a visual analogue scale of 0 to 100 was reached in 95.0% and 59.8% of patients treated with tension-free vaginal tape and polyacrylamide hydrogel, respectively. Thus, polyacrylamide hydrogel did not meet the noninferiority criteria set in our study. As secondary outcomes, the cough stress test was negative in 95.0% of tension-free vaginal tape cases vs 66.4% of polyacrylamide hydrogel cases (difference 28.6%, 95% CI 18.4-38.5). However, most perioperative complications, including those in 19 tension-free vaginal tape cases vs 3 polyacrylamide hydrogel cases (difference 16.0%, 95% CI 7.8-24.9), and all 6 reoperations due to complications (difference 5.9%, 95% CI 1.2-12.4) were associated with tension-free vaginal tape. CONCLUSIONS: Mid urethral tension-free vaginal tape slings were associated with better satisfaction and cure rates than polyacrylamide hydrogel in women with primary stress urinary incontinence. However, complications were mainly associated with tension-free vaginal tape. Thus, tension-free vaginal tape should be offered as first line treatment in women who expect to be completely cured by the initial treatment and are willing to accept the complication risks. Since polyacrylamide hydrogel treatment also provides high satisfaction and cure rates, women with primary stress urinary incontinence can be offered polyacrylamide hydrogel as an alternative treatment.
引用
- Itkonen Freitas AM, Mentula M, Rahkola-Soisalo P, et al. Tension-Free Vaginal Tape Surgery versus Polyacrylamide Hydrogel Injection for Primary Stress Urinary Incontinence: A Randomized Clinical Trial. J Urol. 2019. PMID: 31479396. doi:10.1097/JU.0000000000000517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。